Patents by Inventor Craig E. Crosson

Craig E. Crosson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5441937
    Abstract: Novel neurotrophic factor compositions are provided, obtained from lung tissue. The factors are found to be active on parasympathetic ganglion neurons enhancing acetylcholine activity. The compositions find use in the treatment of a number of eye disorders.
    Type: Grant
    Filed: January 21, 1994
    Date of Patent: August 15, 1995
    Assignee: Houston Biotechnology Incorporated
    Inventors: Thomas L. Wallace, David E. Potter, Craig E. Crosson
  • Patent number: 5166317
    Abstract: Novel neutrotrophic factor compositions are provided, obtained from lung tissue. The factors are found to be active on parasympathetic ganglion neutrons enhancing acetylcholine activity. The compositions find use in the treatment of a number of eye disorders.
    Type: Grant
    Filed: October 31, 1988
    Date of Patent: November 24, 1992
    Assignee: Houston Biotechnology Incorporated
    Inventors: Thomas L. Wallace, David E. Potter, Craig E. Crosson
  • Patent number: 4966577
    Abstract: Disclosed is a composition for preventing secondary cataract formation in the eye following removal of the lens, comprising an antibody specific to particular lens cells related to secondary cataract formation, which antibody is conjugated to an antiproliferative agent. The particularly preferred antiproliferative agents require activation after binding of the antibody to the target cells, and activation may be accomplished by addition of a second composition or by exposure of the eye to electromagnetic energy.Also disclosed is a method of using the composition by administering it directly to the site from which the lens was removed to kill or prevent proliferation of lens cells.
    Type: Grant
    Filed: March 16, 1988
    Date of Patent: October 30, 1990
    Assignee: Allergan, Inc.
    Inventors: Craig E. Crosson, Beverly E. Barton, William H. Garner, Arlene E. Gwon